2m 2m 2m 2m 2m 2m 2m
TONIX PHARM HLD (TNXP)
NASDAQ
$11.78-$0.19 (-1.55%)
Price as of Jun 23, 2026 7:47 PM EDT- $194.5MMarket Cap
- -66.47%1-Year Change
- BiotechnologyIndustry
TONIX PHARM HLD (TNXP)
$11.78-$0.19 (-1.55%)
TNXP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.96 | ||
Change | -$0.24 (-1.97%) | ||
Open | $11.79 | ||
High | $12.58 | ||
Low | $11.78 | ||
Previous Close | $12.20 | ||
Volume | 466,920 | ||
30-Day Average Volume | 563,721 | ||
1-Week Change | 2.84% | ||
1-Month Change | -6.34% | ||
1-Year Change | -66.47% | ||
3-Year Change | -99.77% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 15.9M | ||
Total Assets | $257.9M | ||
Market Cap | $194.5M | ||
Enterprise Value | $9.0M | ||
Period: QTR TTM FY | |||
Revenue | $6.9M | ||
Net Income | -$40.2M | ||
Free Cash Flow | -$44.0M | ||
EBIT | -$40.2M | ||
EBITDA | -$39.6M | ||
Net Working Capital | $177.5M | ||
EPS | -$2.93 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | 1 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 100 | ||
Last Split Date | 02/05/2025 | ||
Earnings & Revenue